CCK-1 receptor modulators
US7250434B2 · kind B2 · utility
0Cited by
7References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2004 |
| Grant date | Jul 31, 2007 |
| Priority date | — |
| Expiry date | Jan 30, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Certain imidazole compounds are CCK1 modulators useful in the treatment of CCK1 mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.